The combination of paclitaxel and carboplatin as second-line chemotherapy can be a preferred regimen for patients with urothelial carcinoma after the failure of gemcitabine and cisplatin chemotherapy.
about
The combination of paclitaxel and carboplatin as second-line chemotherapy can be a preferred regimen for patients with urothelial carcinoma after the failure of gemcitabine and cisplatin chemotherapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The combination of paclitaxel ...... ne and cisplatin chemotherapy.
@en
The combination of paclitaxel ...... ne and cisplatin chemotherapy.
@nl
type
label
The combination of paclitaxel ...... ne and cisplatin chemotherapy.
@en
The combination of paclitaxel ...... ne and cisplatin chemotherapy.
@nl
prefLabel
The combination of paclitaxel ...... ne and cisplatin chemotherapy.
@en
The combination of paclitaxel ...... ne and cisplatin chemotherapy.
@nl
P2093
P2860
P356
P1476
The combination of paclitaxel ...... ne and cisplatin chemotherapy.
@en
P2093
Kenichi Taguchi
Motonobu Nakamura
Mototsugu Shimokawa
Nobuki Furubayashi
Shuhei Kusano
Takahito Negishi
Takuya Yamashita
P2860
P304
P356
10.3892/MCO.2017.1452
P577
2017-10-13T00:00:00Z